ROLE OF CONTRAST-ENHANCED ULTRASOUND IN PULMONARY LESIONS: 5-YEAR EXPERIENCE AT A SINGLE CENTER

(Received 21 June 2021; revised 27 September 2021; in final form 19 October 2021) Abstract-Contrast-enhanced ultrasound (CEUS) for the differentiation of benign and malignant peripheral pulmonary lesions has been considered experimental for many years. This study was aimed at evaluating the feasibility of CEUS as a diagnostic modality in this area of discussion. CEUS diagnostic accuracy was explored by comparison with contrast-enhanced computed tomography (CECT). The collective included 449 patients with 449 definitive diagnoses (benign, 178; malignant, 271). Logistic regression analysis of CEUS data revealed that delayed time to enhancement, chaotic pattern of distribution of vessels and mild extent of enhancement were independent risk factors for predicting malignancy. Time to wash-out and homogeneity of enhancement did not differ between the two groups (p > 0.05). Based on histopathology or clinical follow-up as a reference standard, CEUS and CECT had similar diagnostic accuracies of 80.16% and 81.75%, respectively. CEUS is a potentially useful imaging tool for diagnosing peripheral pulmonary lesions. (E-mail: Ery_nief@lzu.edu.cn) (c) 2021 World Federation for Ultrasound in Medicine & Biology. All rights reserved.